Salarius Pharmaceuticals to Present at the Diamond Equity Research Emerging Growth Invitational Conference

April 4, 2023

https://www.globenewswire.com/news-release/2023/04/04/2641201/0/en/Salarius-Pharmaceuticals-to-Present-at-the-Diamond-Equity-Research-Emerging-Growth-Invitational-Conference.html

HOUSTON, April 04, 2023 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (Nasdaq:SLRX), a clinical-stage biopharmaceutical company using protein inhibition and protein degradation to develop cancer therapies for patients in need of new treatment options, today announced that management will present at the Diamond Equity Research Emerging Growth Invitational virtual investor conference taking place Wednesday, April 5th.

Read more at globenewswire.com

Related news for (SLRX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.